Noticias Grupo Grünenthal

Bienvenido a la sección de Prensa del Grupo Grünenthal

25 nov 2013

Grünenthal launches public tender offer to the shareholders of Empresas Andrómaco

  • Offer period from November 25 to December 24, 2013
  • Offer price of CLP 332.48 per share
  • Offer price represents a premium of 66.99% on the closing price of Sept 6
  • Objective is to acquire all outstanding shares via tender offer

Ampliar información ...

09 sep 2013

Grünenthal signs agreements to acquire Empresas Andrómaco, Chile

  • Grünenthal signed certain agreements with two major shareholders of Empresas Andrómaco, Chile, preparing a potential takeover of the company later in 2013
  • Grünenthal will now conduct a due diligence of Empresas Andrómaco, followed by a potential launch of a public tender offer for all outstanding shares of Laboratorios Andrómaco S.A.
  • Laboratorios Andrómaco S.A. is the Santiago stock exchange listed entity of the Empresas Andrómaco Group

Ampliar información ...

09 sep 2013

Video Statement LATAM Expansion

A Message from Oscar Ferenczi, Executive Vice President Grünenthal Latin America, about the agreements to acquire Empresas Andrómaco, Chile.

Ampliar información ...

04 jul 2013

Grünenthal Group awarded as one of the best employers in Europe and Latin America

Pain specialist participates for the third time in the employee survey and cultural audit of the Great Place to Work® Institute, to reach its self-defined objective of becoming “best employer”.

Ampliar información ...

06 jun 2013

Supporting young scientists on the subject of pain research

EFIC-Grünenthal-Grant awards seven innovative research projects

Brussels/Aachen, 6 June, 2013. For the 8th time the European Federation of IASP® Chapters (EFIC®) in cooperation with the pharmaceutical company Grünenthal Group announced the EFIC-Grünenthal-Grant (E-G-G) – a grant aimed to support young scientists at an early stage of their experimental projects on clinical and human volunteer-based pain research.

Ampliar información ...

29 may 2013

Reorganization of the Corporate Management structure of Grünenthal Group

Aachen (Germany), 29 May, 2013. Grünenthal’s Supervisory Board has decided a reorganization of the Corporate Management structure of the international pharmaceutical company with headquarters in Germany. To enable the realization of our corporate strategy, especially accelerating organic as well as external growth in Latin America, all required sources will now be focused under the leadership of Prof. Eric-Paul Pâques.

Ampliar información ...

Anteriores [10]